aspirin and glp 1 Dr Jones on the Protective Benefit Tolerability of GLP-1 Agonists vs for CRC Prevention Mechanisms by which GLP-1 agonists

In 2023 BPC-157 and a group of related research peptides were placed by the FDA into the interim category 2 list of bulk drug substances that may present significant safety risks a status reflecting immunogenicity, impurity, and human-safety concerns rather than a clean bill of health

Oct 2019;57(2):244-260

Ergonomic interventions for preventing work-related musculoskeletal disorders of the upper limb and neck among office workers

Accessed 6/5/2024, Baenkler HW

For general preventative care and maintaining strong defenses, many people find a monthly session works well

This suggests that a 4 week dietary intervention with RScontaining rice may improve endothelial function by reducing oxidative stress